MCL exhibits a complex pathobiology that includes cyclin D1 overexpression, abnormalities in the DNA damage response, and dysregulation of the PI3K/Akt and NF-κB cell survival pathways [1, 17]. The gene discussed is NFKB1; the disease is mantle cell lymphoma.